Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MHRA OTC initiative

This article was originally published in The Tan Sheet

Executive Summary

The Medicine & Healthcare products Agency will lead "an initiative for the better regulation of over-the-counter medicines," UK Minister for Quality & Patient Safety Jane Kennedy states during the European Self-Medication Industry (AESGP) meeting Nov. 23. The initiative "will determine what measures need to be in place to enable better operation and delivery of over-the-counter medicines regulation," the minister explains. MHRA has invited several organizations to nominate members to participate, including the Proprietary Association of Great Britain, the Department of Health, the Cabinet Office, the National Pharmaceutical Association and the Association of Chief Executives of Voluntary Organizations. The minister requests that the group hold the first meeting before the end of December and "deliver its first proposals to simplify over-the-counter medicines regulation by the end of this financial year"...

You may also be interested in...



DHS Guidance Smooths Potential Wrinkles In US Supplement Industry Being ‘Essential’ Nationwide

VMS businesses are deemed essential in Department of Homeland Security guidance that provides as basis for orders by most states and localities across the US. During an AHPA webinar, attorney Trent Norris says the federal government prefers leaving business exemptions to shut-down decisions to the states.

J&J Ramps Up Manufacturing Capacity To Produce 1 Billion Doses Of Candidate COVID-19 Vaccine

Company expects clinical trials to begin by September and says first batches could be available for emergency use authorization in early 2021; J&J pledges vaccine will be available to public on not-for-profit basis.

FDA To Relax Some Standards For Use Of Surgical Gowns, Gloves, Other Apparel During COVID-19 Crisis

The US FDA wants to expand the availability of surgical apparel – including gowns, hoods and examination gloves – for health care professionals to use for the duration of the COVID-19 public health crisis. That means the agency will “not object” to the use of gowns and gloves providing low-to-minimal protection, as long as they do not create an undue risk to patients or users.

Topics

UsernamePublicRestriction

Register

PS098898

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel